Allozymes' innovative team

Join our team of innovative industry disrupters

Allozymes hosts a team of innovative, inspirational, and creative entrepreneurs and scientists with more than 20 years of experience in enzyme technology, bioprocess design, biotechnology, microfluidics, and machine learning. We are mission-driven, working and learning together to build a better future for humankind, reducing carbon emissions, preserving the environment, and generating innovative solutions to the world’s most pressing issues. We are creating the blueprint for sustainable production. 

Peyman

Peyman Salehian, PhD

CEO, Co-founder
Akbar

Akbar Vahidi, PhD

CTO, Co-founder
Screenshot 2022-06-16 at 2.29.21 PM

Deepak Raghothaman, PhD

Director of Business Development
Screenshot 2022-06-23 at 11.26.40 AM

Ali Fallah-Araghi, PhD

Director of Protein Engineering
Screenshot 2022-06-16 at 2.30.57 PM

Ashley Aw, PhD

Sequencing Scientist
Screenshot 2022-06-16 at 2.31.05 PM

Balaji Sundara Sekar, PhD

Engineering Scientist
Screenshot 2022-06-22 at 10.07.54 AM

Jacky Tan

Research Assistant
Screenshot 2022-06-16 at 2.31.22 PM

Jonathan San

Research Assistant
Norhaziqa

Norhaziqa Reiza

Research Technician
Patrick

Patrick Tan, PhD

Senior Microfluidics Scientist
Screenshot 2022-06-16 at 2.31.38 PM

Pavan Dronamraju

Research Assistant
Reese

Reese Cheam

Research Technician
Screenshot 2022-06-16 at 2.31.46 PM

Renee Leong

Office and Human Resources Manager
Screenshot 2022-06-22 at 10.07.45 AM

Shahla Zavosh

Application Engineer
Screenshot 2022-06-22 at 9.28.05 AM

Tiago Resende, PhD

Senior Computational Biologist

Advisors to Allozymes

Erik (1)

Dr. Erik de Vries

Advisor
Scott

Mr. Scott Chaplin

Advisor
INVESTORS

World-Changing Ventures

Check out our job openings

Subscribe to the newsletter

Peyman

Dr. Peyman is a scientist-entrepreneur with extensive experience in transferring technologies from the lab to the market. He received his Ph.D. from the National University of Singapore (NUS) during his PhD, led industrial-academic collaborations focusing on bioprocess and process scale-up. As a serial entrepreneur, he now leads Allozymes to spearhead an advanced technology to revolutionize biotech adoption in different industries.

He started his first company at 22 leveraging the needed pathway of the lab to market, which grew to a 50-person company. Prior to starting Allozymes, Peyman joined a technology consultant firm as head of business development, expanding the company into East Asia and the Middle East.

Akbar

Dr. Akbar is a scientist-entrepreneur and received his PhD in Biocatlysis from National University of Singapore (NUS). He invented Allozymes’ technology when he was serving as a lead research fellow at NUS.

Akbar has more than 10 years of experience in various aspects of enzyme technology and has delivered several industrial projects for various sectors such as pharma, food, and feed. Now he is leading the development of futuristic biotechnological solutions to the most pressing industrial problems at Allozymes.

Deepak

Dr. Deepak obtained his Ph.D. in 2014 from the National University of Singapore in 3D Biomaterials and Tissue Engineering. He also trained in Design Thinking and Medtech Commercialization with the Singapore Stanford Biodesign Program.

Dr. Deepak furthered his passion for industrial bioprocesses with BTI Biotechnology Institute, A*STAR – Agency for Science, Technology, and Research, managing a small research team and building new IP around biochemical assays from idea to market in a short span of 2 years. Most recently, he was with Ferrero for 5 years leading open innovation and strategic commercial partnerships for APAC and managing Asia Raw materials function in Agri-foodtech, Biotech, Sustainability, and Applied digital solutions.

Ali

Dr. Ali obtained his Ph.D. in Biotechnology from the University of Strasbourg in Andrew Griffiths’ lab developing screening applications for droplet-based microfluidics. Through his Ph.D., he published some of the first in vitro assays for enzyme screening in droplet-based microfluidics and contributed to the development of the technology as a screening tool. 

Most recently, Ali worked at Novozymes for 10 years, where he occupied diverse roles such as Science Manager, Department Manager, Scouting for Innovative Technologies, and Technical Service Manager. At Novozymes he spent most of his years in R&D, engaging in-depth with enzyme and microbial screening, as well as expanding his role to the business side working to answer customer projects with strong innovation. 

Dr. Erik de Vries

Dr. Erik de Vries studied Organic Chemistry at the University of Groningen in The Netherlands. After obtaining his PhD in 1997 and during 8 years of postdoc, he started his own spin-off company involved in enzymatic technology. After a successful sale of the company to Codexis in 2006, Inc, he moved to California to work at Codexis in various functions with increasing responsibility. After Codexis, Erik was Technical Sales Manager LifeTech Resins at Purolite, Sales Manager North America at the strain engineering company Amyris and then West Coast BD Manager at the Swiss pharma contract manufacturer Dottikon Exclusive Synthesis AG.

After moving back to his home base in The Netherlands in 2018, Erik started his own biotechnology consulting company and has been involved worldwide in the early stages of numerous biotech and deep tech start-up initiatives. Erik is currently the CEO of the biotech Enzymicals AG (Greifswald, Germany) and he is a member of the (Technical) Advisory Boards of FabricNano Ltd (London, UK), and of Allozymes.

Mr. Scott Chaplin

Mr. Scott Chaplin earned his Bachelors in Food Sciences from the University of Maryland, and has spent decades working in fragrances, food, biosciences, and more.  Scott is a successful leader of many commercial groups in the global market today.  Having spent the last 30 years in the managerial level of biotechnology and F&F industry, Scott has supported companies to drive a commercial value proposition in the industry with a strategic focus on revenue enhancement, new product and technology introductions, P/L assessments and competitive analysis across North America, Europe, China, etc, thus earning him the name ‘commercial expert’. 

For the past 12 years, Scott has been Principal at SCMC Consulting firm, which focuses on business support to the Flavor, Fragrance and Ingredient industry with emphasis on the F&F, FMCG companies in the Food, Beverage, Confection, Dairy, Pharma, Nutraceutical, Cosmetic and Food Service industries.